Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1816 1
1928 1
1941 1
1942 1
1943 5
1944 1
1946 3
1947 2
1948 4
1949 2
1951 3
1952 1
1953 5
1954 3
1955 4
1956 5
1957 4
1958 4
1959 3
1960 4
1961 3
1962 8
1963 3
1964 16
1965 13
1966 12
1967 7
1968 11
1969 11
1970 7
1971 10
1972 11
1973 20
1974 23
1975 19
1976 30
1977 25
1978 26
1979 19
1980 24
1981 31
1982 33
1983 41
1984 45
1985 50
1986 52
1987 59
1988 54
1989 60
1990 49
1991 56
1992 53
1993 55
1994 61
1995 65
1996 83
1997 64
1998 59
1999 74
2000 87
2001 82
2002 84
2003 86
2004 92
2005 104
2006 100
2007 113
2008 103
2009 120
2010 104
2011 144
2012 138
2013 137
2014 181
2015 145
2016 220
2017 184
2018 142
2019 164
2020 179
2021 196
2022 196
2023 197
2024 31

Text availability

Article attribute

Article type

Publication date

Search Results

4,360 results

Results by year

Filters applied: . Clear all
Page 1
Engineering living therapeutics with synthetic biology.
Cubillos-Ruiz A, Guo T, Sokolovska A, Miller PF, Collins JJ, Lu TK, Lora JM. Cubillos-Ruiz A, et al. Among authors: miller pf. Nat Rev Drug Discov. 2021 Dec;20(12):941-960. doi: 10.1038/s41573-021-00285-3. Epub 2021 Oct 6. Nat Rev Drug Discov. 2021. PMID: 34616030 Review.
Burosumab for the Treatment of Tumor-Induced Osteomalacia.
Jan de Beur SM, Miller PD, Weber TJ, Peacock M, Insogna K, Kumar R, Rauch F, Luca D, Cimms T, Roberts MS, San Martin J, Carpenter TO. Jan de Beur SM, et al. Among authors: miller pd. J Bone Miner Res. 2021 Apr;36(4):627-635. doi: 10.1002/jbmr.4233. Epub 2021 Jan 12. J Bone Miner Res. 2021. PMID: 33338281 Free PMC article. Clinical Trial.
Lenalidomide promotes the development of TP53-mutated therapy-related myeloid neoplasms.
Sperling AS, Guerra VA, Kennedy JA, Yan Y, Hsu JI, Wang F, Nguyen AT, Miller PG, McConkey ME, Quevedo Barrios VA, Furudate K, Zhang L, Kanagal-Shamanna R, Zhang J, Little L, Gumbs C, Daver N, DiNardo CD, Kadia T, Ravandi F, Kantarjian H, Garcia-Manero G, Futreal PA, Ebert BL, Takahashi K. Sperling AS, et al. Among authors: miller pg. Blood. 2022 Oct 20;140(16):1753-1763. doi: 10.1182/blood.2021014956. Blood. 2022. PMID: 35512188 Free PMC article.
TET2-mutant clonal hematopoiesis and risk of gout.
Agrawal M, Niroula A, Cunin P, McConkey M, Shkolnik V, Kim PG, Wong WJ, Weeks LD, Lin AE, Miller PG, Gibson CJ, Sekar A, Schaefer IM, Neuberg D, Stone RM, Bick AG, Uddin MM, Griffin GK, Jaiswal S, Natarajan P, Nigrovic PA, Rao DA, Ebert BL. Agrawal M, et al. Among authors: miller pg. Blood. 2022 Sep 8;140(10):1094-1103. doi: 10.1182/blood.2022015384. Blood. 2022. PMID: 35714308 Free PMC article.
Cancer and COVID-19: analysis of patient outcomes.
Aboueshia M, Hussein MH, Attia AS, Swinford A, Miller P, Omar M, Toraih EA, Saba N, Safah H, Duchesne J, Kandil E. Aboueshia M, et al. Among authors: miller p. Future Oncol. 2021 Sep;17(26):3499-3510. doi: 10.2217/fon-2021-0121. Epub 2021 Jul 15. Future Oncol. 2021. PMID: 34263660 Free PMC article.
An improved index for diagnosis and mortality prediction in malignancy-associated hemophagocytic lymphohistiocytosis.
Zoref-Lorenz A, Murakami J, Hofstetter L, Iyer S, Alotaibi AS, Mohamed SF, Miller PG, Guber E, Weinstein S, Yacobovich J, Nikiforow S, Ebert BL, Lane A, Pasvolsky O, Raanani P, Nagler A, Berliner N, Daver N, Ellis M, Jordan MB. Zoref-Lorenz A, et al. Among authors: miller pg. Blood. 2022 Feb 17;139(7):1098-1110. doi: 10.1182/blood.2021012764. Blood. 2022. PMID: 34780598 Free PMC article.
Degradation of GSPT1 causes TP53-independent cell death in leukemia while sparing normal hematopoietic stem cells.
Sellar RS, Sperling AS, Słabicki M, Gasser JA, McConkey ME, Donovan KA, Mageed N, Adams DN, Zou C, Miller PG, Dutta RK, Boettcher S, Lin AE, Sandoval B, Quevedo Barrios VA, Kovalcik V, Koeppel J, Henderson EK, Fink EC, Yang L, Chan A, Pokharel SP, Bergstrom EJ, Burt R, Udeshi ND, Carr SA, Fischer ES, Chen CW, Ebert BL. Sellar RS, et al. Among authors: miller pg. J Clin Invest. 2022 Aug 15;132(16):e153514. doi: 10.1172/JCI153514. J Clin Invest. 2022. PMID: 35763353 Free PMC article.
4,360 results